Physician profile
Donald Hohman
NPI 1801235833
$537,406.42
in general payments reported to CMS, 2019-2025
45 companies · $51K in 2025
The $51K reported for 2025 was more than what 88% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $145K · 2020: $89K · 2021: $128K · 2022: $46K · 2023: $42K · 2024: $36K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $73K · Royalty Or License: $19K · Travel and Lodging: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $3,472 · Debt Forgiveness: $2,490 · Honoraria: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,545.81 |
| Royalty Or License | $19,437.00 |
| Travel and Lodging | $18,366.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,175.00 |
| Food and Beverage | $3,472.33 |
| Debt Forgiveness | $2,490.00 |
| Honoraria | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $104,289.62 | 2020-2025 | Celleraterx, Biasurge, Celleraterx |
| Limacorporate S.P.A. | $85,705.73 | 2019-2022 | |
| Advanced Orthopaedic Solutions, INC. | $79,365.72 | 2019-2020 | |
| Arthrex, INC. | $56,926.34 | 2021-2024 | |
| Encore Medical, Lp | $43,053.03 | 2020-2022 | |
| Kyocera Medical Technologies, INC. | $29,818.39 | 2019-2025 | |
| Lima USA, INC. | $23,524.98 | 2019-2020 | |
| Orthalign INC | $21,695.61 | 2019-2023 | Orthalign Plus |
| Signature Orthopaedics USA Corp | $19,437.00 | 2023-2025 | |
| Medical Device Business Services, INC. | $16,254.16 | 2021-2024 | |
| Uoc USA INC | $13,995.35 | 2021-2025 | Ums U3, Conformity, U-Star II, U2 |
| Corin USA | $11,561.36 | 2019 | |
| Wound Management Technologies, INC | $11,102.05 | 2019 | |
| Depuy Synthes Products, INC. | $7,985.64 | 2023-2024 | Velys |
| Omnilife Science, INC | $3,977.13 | 2020-2025 | Unity Total Knee System, Apollo Hip V (Fka) Omnihip, Various Products |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Engage Uni, LLC | $2,814.00 | 2020-2021 | |
| Acera Surgical, INC. | $2,490.00 | 2025 | Restrata Wound Matrix |
| Bone Support INC. | $832.10 | 2022-2025 | Ceramentbone Void Filler, Cerament G |
| Biocomposites INC | $485.19 | 2019-2022 | |
| Stryker Corporation | $243.84 | 2023-2024 | Salvation, Axsos, Tritanium |
| Conformis, INC. | $239.54 | 2019 | |
| Pylant Medical | $210.72 | 2022-2024 | |
| Smith+Nephew, INC. | $153.81 | 2019-2025 | Stravix, Pico 7 |
| Djo, LLC | $150.69 | 2019 | |
| Kinamed, INC. | $123.00 | 2023 | |
| Seaspine Orthopedics Corporation | $121.71 | 2022 | |
| Davol INC. | $95.45 | 2022-2023 | Arista Ah Flexitip |
| Innovation Technologies INC | $93.23 | 2023-2025 | Irrisept |
| Carbofix Orthopedics INC | $92.36 | 2022 | |
| Depuy Synthes Sales INC. | $80.24 | 2022-2024 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $58.98 | 2020-2021 | |
| Becton, Dickinson and Company | $50.75 | 2025 | Arista |
| Horizon Therapeutics Plc | $49.68 | 2019 | |
| Kerecis Limited | $45.32 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $44.44 | 2024 | Durolane |
| Pacira Pharmaceuticals Incorporated | $39.92 | 2021-2023 | Exparel, Iovera, Zilretta |
| Ferring Pharmaceuticals INC. | $36.94 | 2019-2022 | |
| Integra Lifesciences Corporation | $36.80 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $31.21 | 2023-2024 | Caldolor |
| Convatec INC. | $28.79 | 2019 | |
| Ethicon US, LLC | $17.19 | 2023 | Stratafix |
| My01 INC. | $15.48 | 2022 | |
| Ossur Americas, INC. | $13.49 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.36 | 2022 | |
| Osteoremedies, LLC | $6.08 | 2025 | Biobrush |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,700.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Hohman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.